BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1657438)

  • 1. Dihydropyridine receptors are primarily functional L-type calcium channels in rabbit ventricular myocytes.
    Lew WY; Hryshko LV; Bers DM
    Circ Res; 1991 Oct; 69(4):1139-45. PubMed ID: 1657438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of oxygen free radicals on calcium current and dihydropyridine binding sites in guinea-pig ventricular myocytes.
    Guerra L; Cerbai E; Gessi S; Borea PA; Mugelli A
    Br J Pharmacol; 1996 Jul; 118(5):1278-84. PubMed ID: 8818354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the number of dihydropyridine receptors with the number of functional L-type calcium channels in embryonic heart.
    Aiba S; Creazzo TL
    Circ Res; 1993 Feb; 72(2):396-402. PubMed ID: 8380359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of binding of dihydropyridine calcium channel ligands to skeletal muscle membranes: evidence for low-affinity sites and for the involvement of G proteins.
    Dunn SM; Bladen C
    Biochemistry; 1991 Jun; 30(23):5716-21. PubMed ID: 1645998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
    Murphy BJ; Rogers CA; Sunahara RK; Lemaire S; Tuana BS
    Mol Pharmacol; 1990 Feb; 37(2):173-81. PubMed ID: 2154669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
    Wei XY; Rutledge A; Triggle DJ
    Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of pinaverium (a quaternary ammonium compound) with 1,4-dihydropyridine binding sites in rat ileum smooth muscle.
    Feron O; Wibo M; Christen MO; Godfraind T
    Br J Pharmacol; 1992 Feb; 105(2):480-4. PubMed ID: 1313732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain.
    Grassegger A; Striessnig J; Weiler M; Knaus HG; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):752-9. PubMed ID: 2561307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dihydropyridines on calcium channels in isolated smooth muscle cells from rat vena cava.
    Mironneau J; Yamamoto T; Sayet I; Arnaudeau S; Rakotoarisoa L; Mironneau C
    Br J Pharmacol; 1992 Feb; 105(2):321-8. PubMed ID: 1373097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydropyridine receptor binding sites in the cardiomyopathic hamster heart are unchanged from control.
    Bazan E; Sole MJ; Schwartz A; Johnson CL
    J Mol Cell Cardiol; 1991 Feb; 23(2):111-7. PubMed ID: 1648625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding Ca2+ to intracellular or to extracellular sites of dihydropyridine receptor of rabbit skeletal muscle discriminates between in vitro binding of Ca2+-channel agonist and antagonist.
    Kanngiesser U; Pongs O
    Eur J Biochem; 1989 May; 181(2):467-73. PubMed ID: 2540975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit.
    Striessnig J; Murphy BJ; Catterall WA
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10769-73. PubMed ID: 1660150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic administration of nifedipine induces up-regulation of functional calcium channels in rat myocardium.
    Morgan PE; Aiello EA; Chiappe de Cingolani GE; Mattiazzi AR; Cingolani HE
    J Mol Cell Cardiol; 1999 Oct; 31(10):1873-83. PubMed ID: 10525425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cardiac L-type calcium channels by quaternary amlodipine: implications for pharmacokinetics and access to dihydropyridine binding site.
    Kwan YW; Bangalore R; Lakitsh M; Glossmann H; Kass RS
    J Mol Cell Cardiol; 1995 Jan; 27(1):253-62. PubMed ID: 7760349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamic and kinetic aspects of agonist and antagonist binding to 1,4-dihydropyridine receptors.
    Zheng W; Hawthorn M; Triggle DJ
    Eur J Pharmacol; 1991 Oct; 208(2):137-47. PubMed ID: 1724760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct contact between sympathetic neurons and rat cardiac myocytes in vitro increases expression of functional calcium channels.
    Ogawa S; Barnett JV; Sen L; Galper JB; Smith TW; Marsh JD
    J Clin Invest; 1992 Apr; 89(4):1085-93. PubMed ID: 1313444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced calcium sensitivity of dihydropyridine binding to calcium channels in spontaneously hypertensive rats.
    Ebata H; Natsume T; Mitsuhashi T; Yaginuma T
    Hypertension; 1991 Feb; 17(2):234-41. PubMed ID: 1846842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced L-type calcium current in the embryonic chick heart with persistent truncus arteriosus.
    Creazzo TL
    Circ Res; 1990 Jun; 66(6):1491-8. PubMed ID: 1693103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of dihydropyridine-sensitive calcium channels by the plant alkaloid ryanodine.
    Valdivia HH; Coronado R
    FEBS Lett; 1989 Feb; 244(2):333-7. PubMed ID: 2537759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological properties of neonatal mouse cardiac myocytes in primary culture.
    Nuss HB; Marban E
    J Physiol; 1994 Sep; 479 ( Pt 2)(Pt 2):265-79. PubMed ID: 7799226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.